Cleared Special

DIMENSION RXL MAX WITH STREAMLAB ANALYTICAL WORKCELL AND SAMPLE TRANSFER MODULE (K043546) - FDA 510(k) Clearance

Class I Chemistry device.

K043546 · Dade Behring, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2005
Decision
26d
Days
Class 1
Risk

K043546 is an FDA 510(k) clearance for the DIMENSION RXL MAX WITH STREAMLAB ANALYTICAL WORKCELL AND SAMPLE TRANSFER MODULE. Classified as Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides (product code CDT), Class I - General Controls.

Submitted by Dade Behring, Inc. (Newark, US). The FDA issued a Cleared decision on January 18, 2005 after a review of 26 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1705 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Dade Behring, Inc. devices

Submission Details

510(k) Number K043546 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 2004
Decision Date January 18, 2005
Days to Decision 26 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
62d faster than avg
Panel avg: 88d · This submission: 26d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code CDT Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1705
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CDT Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides

All 150
Devices cleared under the same product code (CDT) and FDA review panel - the closest regulatory comparables to K043546.
TGL FLEX REAGENT CARTRIDGE
K010871 · Dade Behring, Inc. · Jul 2001
A-GENT TRIGLLYCERIDES GPO
K874187 · Abbott Laboratories · Jan 1988
IQ TRIGLYCERIDES
K864268 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Dec 1986
VISION TRIGLYCERIDES
K850031 · Abbott Laboratories · Feb 1985
QCA TRIGLYCERIDES
K842891 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Aug 1984
DELTA TEST TRIGLYCERIDES
K802136 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Oct 1980